Zhou, Aifen – Trademark Portfolio

Entity Type: 01

Zhou, Aifen has 3 U.S. trademark filings recorded with the United States Patent and Trademark Office (USPTO). Of these, 1 is successfully registered — a 100% registration rate, with 2 applications currently pending. The portfolio includes marks such as PUGAILA. Filings span 3 Nice Classification classes, with the highest activity in Class 24 (Fabrics) and Class 10 (Medical Apparatus). This trademark owner is based in Quzhou, Zhejiang.

No. 36, Shangwu, Zhengcun Village,

Shuangta Street, Jiangshan

Quzhou, Zhejiang 324100 , CN

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Zhou, Aifen's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

24
Fabrics (1 filing)

Textiles and textile goods; bed covers; table covers

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

28
Toys & Sporting Goods (1 filing)

Games and playthings; gymnastic and sporting articles; decorations for Christmas trees

Frequently Asked Questions

How many trademarks does Zhou, Aifen have?

Zhou, Aifen has 3 U.S. trademarks filed with the USPTO. Of these, 1 registered, 2 pending.

What trademark classes does Zhou, Aifen file in?

Zhou, Aifen files trademarks across 3 Nice Classification classes. The most active classes are Class 24 (Fabrics), Class 10 (Medical Apparatus), Class 28 (Toys & Sporting Goods). Class 24 covers textiles and textile goods; bed covers; table covers.

What are Zhou, Aifen's most well-known trademarks?

Zhou, Aifen's registered trademark portfolio includes well-known marks such as PUGAILA. These are among 1 currently registered trademark in the portfolio.

What is Zhou, Aifen's trademark registration success rate?

Zhou, Aifen has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 2 applications are pending review.